expeditiously as possible. pfizer already has authorization for that age group. are there any lingering concerns out there for any potential side effects for that age group? >> i think when we think about younger and younger demographic, as we do these bridging-down studies, pfizer and moderna have gotten it absolutely right that they must do a dose finding phase. because as we get younger, our immune systems are less mature. so, we see that pfizer reduced its dose by two-thirds. and we see that moderna halved its dose. we may see that, as we get to younger and younger demographics, lower doses as well. absolutely, one of the tenets of medicine, you always want to give the least amount of medication for the maximal effect. we will look for that in children as well. >> dr. jane morgan, always good to see you, be well. >> thanks, great to see you as